Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronald de Wit

Showing results (161-170 of 175) with videos related to

Pageof 18
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 11, 2018
Risk of Solid Cancer After Treatment of Testicular Germ Cell Cancer in the Platinum EraHarmke J Groot, Sjoukje Lubberts, Ronald de Wit, et al.
British Journal of Cancer|October 10, 2018
Risk of diabetes after para-aortic radiation for testicular cancerHarmke J Groot, Jourik A Gietema, Berthe M P Aleman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2022
Putative Biomarkers of Clinical Benefit With Pembrolizumab in Advanced Urothelial Cancer: Results from the KEYNOTE-045 and KEYNOTE-052 Landmark TrialsJoaquim Bellmunt, Ronald de Wit, Yves Fradet, et al.
European Urology Oncology|October 12, 2019
Real-world Outcomes of Sequential Androgen-receptor Targeting Therapies with or Without Interposed Life-prolonging Drugs in Metastatic Castration-resistant Prostate Cancer: Results from the Dutch Castration-resistant Prostate Cancer RegistryMalou C P Kuppen, Hans M Westgeest, Alphonsus J M van den Eertwegh, et al.
International Journal of Cancer|December 27, 2023
Prevalence of neoplasia at colonoscopy among testicular cancer survivors treated with platinum-based chemotherapyEmilie C H Breekveldt, Berbel L M Ykema, Tanya M Bisseling, et al.
Clinical Genitourinary Cancer|August 24, 2019
Second-Line Cabazitaxel Treatment in Castration-Resistant Prostate Cancer Clinical Trials Compared to Standard of Care in CAPRI: Observational Study in the NetherlandsHans M Westgeest, Malou C P Kuppen, Alphonsus J M van den Eertwegh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2021
Predicting Outcomes in Men With Metastatic Nonseminomatous Germ Cell Tumors (NSGCT): Results From the IGCCCG Update ConsortiumSilke Gillessen, Nicolas Sauvé, Laurence Collette, et al.
European Urology Focus|July 30, 2017
Differences in Trial and Real-world Populations in the Dutch Castration-resistant Prostate Cancer RegistryHans M Westgeest, Carin A Uyl-de Groot, Reindert J A van Moorselaar, et al.
European Journal of Cancer (Oxford, England : 1990)|November 2, 2022
CABA-V7: a prospective biomarker selected trial of cabazitaxel treatment in AR-V7 positive prostate cancer patientsKhrystany T Isebia, Bianca Mostert, Bodine P S Belderbos, et al.
European Journal of Cancer (Oxford, England : 1990)|April 2, 2024
Impact of teratoma on survival probabilities of patients with metastatic non-seminomatous germ cell cancer: Results from the IGCCCG Update ConsortiumEmanuel Bührer, David D'Haese, Gedske Daugaard, et al.
Pageof 18

Showing results (161-170 of 175) with videos related to

Sort By:
Pageof 18
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 11, 2018
Risk of Solid Cancer After Treatment of Testicular Germ Cell Cancer in the Platinum EraHarmke J Groot, Sjoukje Lubberts, Ronald de Wit, et al.
British Journal of Cancer|October 10, 2018
Risk of diabetes after para-aortic radiation for testicular cancerHarmke J Groot, Jourik A Gietema, Berthe M P Aleman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2022
Putative Biomarkers of Clinical Benefit With Pembrolizumab in Advanced Urothelial Cancer: Results from the KEYNOTE-045 and KEYNOTE-052 Landmark TrialsJoaquim Bellmunt, Ronald de Wit, Yves Fradet, et al.
European Urology Oncology|October 12, 2019
Real-world Outcomes of Sequential Androgen-receptor Targeting Therapies with or Without Interposed Life-prolonging Drugs in Metastatic Castration-resistant Prostate Cancer: Results from the Dutch Castration-resistant Prostate Cancer RegistryMalou C P Kuppen, Hans M Westgeest, Alphonsus J M van den Eertwegh, et al.
International Journal of Cancer|December 27, 2023
Prevalence of neoplasia at colonoscopy among testicular cancer survivors treated with platinum-based chemotherapyEmilie C H Breekveldt, Berbel L M Ykema, Tanya M Bisseling, et al.
Clinical Genitourinary Cancer|August 24, 2019
Second-Line Cabazitaxel Treatment in Castration-Resistant Prostate Cancer Clinical Trials Compared to Standard of Care in CAPRI: Observational Study in the NetherlandsHans M Westgeest, Malou C P Kuppen, Alphonsus J M van den Eertwegh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2021
Predicting Outcomes in Men With Metastatic Nonseminomatous Germ Cell Tumors (NSGCT): Results From the IGCCCG Update ConsortiumSilke Gillessen, Nicolas Sauvé, Laurence Collette, et al.
European Urology Focus|July 30, 2017
Differences in Trial and Real-world Populations in the Dutch Castration-resistant Prostate Cancer RegistryHans M Westgeest, Carin A Uyl-de Groot, Reindert J A van Moorselaar, et al.
European Journal of Cancer (Oxford, England : 1990)|November 2, 2022
CABA-V7: a prospective biomarker selected trial of cabazitaxel treatment in AR-V7 positive prostate cancer patientsKhrystany T Isebia, Bianca Mostert, Bodine P S Belderbos, et al.
European Journal of Cancer (Oxford, England : 1990)|April 2, 2024
Impact of teratoma on survival probabilities of patients with metastatic non-seminomatous germ cell cancer: Results from the IGCCCG Update ConsortiumEmanuel Bührer, David D'Haese, Gedske Daugaard, et al.
Pageof 18